Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)
Close on Nov 17, 2026Market cap $6.04MP/E –Yield –
Actuate Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Actuate Therapeutics's enterprise value was $2.83M on Nov 11, 2026, against $160.42M a year earlier. Over the last 2 years it ranged from $2.83M to $228.54M, with a median of $115.45M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.83M | -97.7% |
| 2025 | Dec 31, 2025 | $125.32M | -11.7% |
| 2024 | Dec 31, 2024 | $141.95M | – |
See a number that looks wrong?